Janus kinase (JAK) inhibitors represent a promising class of small molecule inhibitors that treat a range of inflammatory skin diseases, such as atopic dermatitis (AD), psoriasis, and alopecia areata. Although the evidence for their use in allergic contact dermatitis (ACD) remains limited, early results from animal studies and case reports are promising. Herein, we provide an overview of JAK inhibitors and the evidence for their use in ACD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.12788/cutis.0705 | DOI Listing |
Publication Analysis
Top Keywords
janus kinase
8
allergic contact
8
contact dermatitis
8
jak inhibitors
8
inhibitors
4
kinase inhibitors
4
inhibitors promising
4
promising therapeutic
4
therapeutic option
4
option allergic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!